There are no Focus articles on ATTBF.
There are no Transcripts on ATTBF.
There are no News articles on ATTBF.
We currently have no Breaking News on this stock.
ATTBF vs. ETF Alternatives
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.
Other News & PR